I migliori medici di Test per le mutazioni di KRAS, NRAS, BRAF a Istanbul - TOP-11 medici

Il Dottor Mustafa Solak è un oncologo specializzato nella cura del cancro al seno, testicoli, ovaie, polmoni, testa, collo e tumori gastrointestinali. Ha conseguito la laurea presso la Facoltà di Medicina dell'Università di Hacettepe. Ha completato la sua specializzazione presso l'Ospedale di Ricerca e Formazione Şişli Etfal a Istanbul e successivamente ha svolto un tirocinio presso l'Istituto Oncologico dell'Università di Hacettepe.

Il Dottor Solak ha gestito numerosi casi oncologici complessi. Ha contribuito allo sviluppo dell'oncologia clinica in centri di eccellenza, incluso il centro oncologico MD Anderson presso l'Università del Texas. Ha inoltre lavorato all’ospedale universitario Hitit di Çorum e presso il Medical Park Hospital. La sua esperienza testimonia un profondo impegno nel trattamento e nella ricerca sul cancro.

Il Dottor Serdar Turhal è un oncologo altamente qualificato, specializzato in oncologia medica e chemioterapia del cancro al seno presso il Centro Medico Anadolu. È membro di numerose associazioni oncologiche internazionali ed è autore di numerosi articoli in pubblicazioni internazionali. Si specializza nei fattori di prognosi e nella terapia delle neoplasie maligne del tratto gastrointestinale. Per ottenere una consulenza dal Dottor Turhal, lasciate una richiesta su Bookimed.

Assoc. Prof. Dr. Abdulcabbar Kartal is a distinguished colorectal and general surgeon practicing at Anadolu Medical Center in Istanbul. With over 17 years of surgical experience, he specializes in colorectal surgery, HIPEC (hyperthermic intraperitoneal chemotherapy) for peritoneal cancers, bariatric surgery, and minimally invasive procedures.

Dr. Kartal graduated from Istanbul University Faculty of Medicine in 2007 and completed his general surgery specialization at Istanbul Şişli Etfal Training and Research Hospital (2007-2013). He served as Assistant Professor at Istanbul Okan University (2016-2020) before receiving his Associate Professor title in 2020. In 2021, he earned the prestigious FEBS-C certification from the European Society of Coloproctology and became a Fellow of the American College of Surgeons (FACS).

Dr. Kartal has published over 40 articles in international peer-reviewed journals and is an active member of the Turkish Society of Colon and Rectal Surgery, European Society of Coloproctology, and Turkish Surgical Association.

Dr. Sertkaya graduated from Konya Meram Science High School in 2001 and entered Gazi University Medical Faculty the same year, graduating in 2008. He completed his urology specialization at Haydarpaşa Numune Training and Research Hospital in 2014, becoming a urology specialist.

Since becoming a specialist, he has focused on the sub-branch of Andrology, attending various training sessions and conferences and performing surgeries with some of the world's leading Andrology professors. In 2017, he passed the written and oral proficiency exams conducted by the European Association of Urology, earning the title of "FEBU."

In 2020, Dr. Sertkaya achieved the rank of Associate Professor of Urology. His journey in Urology and Andrology, which began in 2008, continues at the Andro Expertise Male Health and Aesthetics Center, which he founded in 2022. He sees patients in his own clinic and performs surgeries at affiliated hospitals.

Il Dott. Sinan Karaaslan è un medico oncologo presso il Anadolu Medical Center (dal 2014). Tratta il cancro al seno, il cancro colon-rettale e i tumori del sistema genitourinario; è nel campo dell'oncologia medica dal 2003. Membro dell'Associazione Medica Turca, della Società Turca di Oncologia Medica e della Società Turca di Cancro Polmonare.

Perché i pazienti scelgono e si fidano del Dott. Karaaslan:

• Tratta casi complessi di cancro al seno, intestinale e del sistema genitourinario - utilizza terapie sistemiche moderne tenendo conto del tipo e dello stadio del tumore.
• Membro dell'Associazione Medica Turca, della Società Turca di Oncologia Medica e della Società Turca di Cancro Polmonare.
• Autore di numerosi articoli scientifici e materiale per i pazienti su chemio- e immunoterapia.
• Il Dottore lavora in un centro con lo status di ESMO Designated Centre e accreditazione JCI ed è in collaborazione strategica con Johns Hopkins Medicine International - una delle principali cliniche degli Stati Uniti. Per il paziente questo significa trattamento secondo i protocolli americani e utilizzo di attrezzature moderne.

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Elnur Sahibov is a licensed Radiation Oncologist with 8 years of medical training and clinical experience. He completed his undergraduate and specialization studies at Marmara University Faculty of Medicine. From 2012 to 2016, he focused on advanced radiation oncology techniques.

Dr. Sahibov is known for his expertise in cancer treatment. He has helped improve patient outcomes and uses evidence-based protocols. He is accredited by leading medical institutions and is dedicated to ongoing professional development in oncology.